Showing 1 - 3 results of 3 for search 'Paolo Morelli', query time: 0.02s Refine Results
  1. 1
    Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy

    Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy by Francesca Fiorentino, Beatrice Canali, Paolo Morelli, Federica Demma

    Published 2023-01-01
    Get full text
    Article
  2. 2
    Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy

    Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy by Francesca Fiorentino, Chiara Vassallo, Beatrice Canali, Paolo Morelli, Silvia Ripoli, Laura Fioravanti

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy

    Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy by Chiara Bini, Andrea Marcellusi, Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Molinari, Paolo Morelli, Stanimira Krotneva, Shujun Li

    Published 2024-12-01
    Get full text
    Article

Search Tools: